COVID-19: Mechanisms of Vaccination and Immunity.
Options
BORIS DOI
Publisher DOI
PubMed ID
32707833
Description
Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines that induce large quantities of high affinity virus-neutralizing antibodies may optimally prevent infection and avoid unfavorable effects. Vaccination trials require precise clinical management, complemented with detailed evaluation of safety and immune responses. Here, we review the pros and cons of available vaccine platforms and options to accelerate vaccine development towards the safe immunization of the world's population against SARS-CoV-2. Favorable vaccines, used in well-designed vaccination strategies, may be critical for limiting harm and promoting trust and a long-term return to normal public life and economy.
Date of Publication
2020-07-22
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
COVID-19 SARS-CoV-2 immunity nucleic acid tests serology vaccination
Language(s)
en
Additional Credits
Universitätsklinik für Rheumatologie, Immunologie und Allergologie
Series
Vaccines
Publisher
MDPI
ISSN
2076-393X
Access(Rights)
open.access